Bayer Corp

XOMA is among the leaders in the discovery, development and manufacture of therapeutic antibodies. The company s broad technology platform, scientific expertise and integrated product development infrastructure extends from antibody discovery to regulatory approval. It is a proven development partner and technology licensor, receiving royalties from Genentech for Raptiva and Lucentis. XOMA s pipeline includes an expanding number of proprietary products and collaborative programs at various stages of clinical and preclinical development. The company s operational infrastructure enables it to produce product candidates in compliance with cGMP using mammalian and microbial systems for preclinical and clinical purposes to meet the needs of many product development programs. Its additional capabilities include cell line development, process and assay creation, contract manufacturing and regulatory compliance. XOMA has operated for more than 25 years and has a location in Berkeley, Calif.

Parnell Pharmaceuticals, Inc., based in San Rafael, CA, specializes in developing patented topical formulations aimed at combating dryness and infections, including dry mouth, nasal dryness, and feminine dryness. The company uniquely incorporates Yerba Santa, a natural herbal extract, in its products, enhancing moisturization and lubricity without animal testing, alcohol, gluten, or sugar. Among its offerings are Mouth Kote Dry Mouth Spray and Pretz Nasal Spray, both designed to provide effective relief for patients seeking quality-of-life improvements. Parnell Pharmaceuticals is committed to using innovative technology while honoring the traditional uses of native flora, particularly the Yerba Santa plant, which has been valued by various Indigenous tribes for centuries. Generated from the website